Boston Scientific and Accenture develop new digital health solution for chronic cardiovascular diseases

28 January 2016 (Last Updated November 22nd, 2018 11:18)

US-based medical device firm Boston Scientific, along with Accenture, has developed a new cloud-based and data-driven digital health solution, Advantics Care Pathway Transformation, to help improve patient outcomes and reduce costs.

US-based medical device firm Boston Scientific, along with Accenture, has developed a new cloud-based and data-driven digital health solution, Advantics Care Pathway Transformation, to help improve patient outcomes and reduce costs.

The new solution has been designed to be used in hospitals to treat patients with chronic cardiovascular diseases.

The Advantics solution will allow providers to make more proactive and informed decisions based on insights into the patient population in order to improve the care a patient experiences from hospital stay through post-discharge care and in-home support.

"The Care Pathway Transformation solution is designed to support healthcare professionals and patients to have more informed relationships, leading to better health outcomes and lower costs for health systems."

By using Accenture's analytics insights platform, the solution offers actionable insights into care coordination and patient population health patterns.

The solution will focus on three major measurements, including pathway analytics, care management and patient engagement.

When developing the solution, both the parties have worked with two Scandinavia's hospitals, Sweden's Karolinska University Hospital and Finland's Tampere Heart Hospital to evaluate the current state of care delivery for heart failure patients and identify opportunities for improvement at each hospital.

Tampere Heart Hospital CEO Dr Kari Niemelä said: "The collaboration with Boston Scientific and Accenture exposed significant opportunities to increase provider collaboration and improve the quality of care that patients experience when coming to our hospital.

"For example, we identified a 25% unnecessary heart failure readmissions rate, and therefore a definite need for better care coordination, supported by modern technology and processes that can decrease overall costs."

The firms initially intend to provide the solution to hospitals in the UK and Scandinavia, and are planning for pilot projects across the Europe and the US.

Boston Scientific president and CEO Mike Mahoney said: "Boston Scientific and Accenture designed this digital health platform to help providers standardise care, reduce overall length of stay and lower readmission rates.

"The Care Pathway Transformation solution is designed to support healthcare professionals and patients to have more informed relationships, leading to better health outcomes and lower costs for health systems."